Results 201 to 210 of about 1,371,434 (244)
Some of the next articles are maybe not open access.
Bone Marrow Purging for Autologous Bone Marrow Transplantation
Leukemia & Lymphoma, 1993High dose therapy with the resulting myeloablation rescued by infusion of autologous bone marrow (ABMT) has become a major treatment option for an increasing number of patients with hematologic and solid tumors. ABMT has several potential advantages over allogeneic transplantation.
J G, Gribben, L M, Nadler
openaire +2 more sources
Critical Reviews in Oncology/Hematology, 1985
Bone marrow transplantation is increasingly used to treat a broad spectrum of human diseases including aplastic anemia, leukemia, solid tumors, immune and genetic disorders. In certain circumstances the role of transplantation is reasonably well established, such as aplastic anemia and resistant leukemia. In other circumstances there is controversey as
openaire +3 more sources
Bone marrow transplantation is increasingly used to treat a broad spectrum of human diseases including aplastic anemia, leukemia, solid tumors, immune and genetic disorders. In certain circumstances the role of transplantation is reasonably well established, such as aplastic anemia and resistant leukemia. In other circumstances there is controversey as
openaire +3 more sources
Bone marrow transplantation for myeloblastoma
European Journal of Haematology, 1988A 20‐yr‐old man with bulky mediastinal and retroperitoneal tumour masses identified as myeloblastoma is described. After a partial remission was induced by aggressive chemotherapy, mediastinal irradiation and retroperitoneal tumour resection, the patient received an allogeneic marrow graft from his HLA‐identical sister.
K, Quabeck +7 more
openaire +2 more sources
A History of Bone Marrow Transplantation
Immunology and Allergy Clinics of North America, 2010The last 40 years has seen the emergence of hematopoietic stem cell transplantation as a therapeutic modality for fatal diseases and as a curative option for individuals born with inherited disorders that carry limited life expectancy and poor quality of life.
M Teresa, de la Morena, Richard A, Gatti
openaire +3 more sources
Allogeneic Bone Marrow Transplantation
CRC Critical Reviews in Clinical Laboratory Sciences, 1983Allogeneic bone marrow transplantation now has an established place in the treatment of severe aplastic anemia and acute leukemia. Major problems to be overcome in transplantation in patients with aplastic anemia are marrow graft rejection and graft vs. host disease.
Paul L. Weiden, John G. Batsakis
openaire +2 more sources
Bone marrow transplant in adrenoleukodystrophy
Neurology, 1984An allogeneic bone marrow transplant (BMT) from a normal HLA identical sibling donor was performed in a 13-year-old boy with rapidly progressive adrenoleukodystrophy (ALD). Engraftment and complete hematologic recovery occurred within 4 weeks, but neurologic deterioration continued. The patient died of an adenovirus infection 141 days after BMT. ALD is
Hugo W. Moser +13 more
openaire +2 more sources
Hyperuricemia and Bone Marrow Transplantation
2004Blood uric acid levels and purine metabolism are affected in many ways after bone marrow transplantation (BMT). Although BMT is usually performed when patients have a low residual disease burden, a proportion of them are still at risk of tumor lysis syndrome, even with limited disease or after nonmyeloablative conditioning regimens; moreover, an ...
Giorgio Lambertenghi, Deliliers +1 more
openaire +2 more sources
Autologous Bone Marrow Transplantation
Annual Review of Medicine, 1989Autologous bone marrow transplantation in the acute leukemias and lymphomas offers potentially curative treatment in patients who do not have a histocompatible, allogeneic donor. Results of marrow autografting in the lymphomas are especially encouraging, with disease-free survivals of 50-60% in patients who have failed primary and secondary treatment ...
G W, Santos, A M, Yeager, R J, Jones
openaire +2 more sources
BONE MARROW TRANSPLANTATION IN LEUKEMIA
Journal of Hematotherapy, 1994Bone marrow transplants are increasingly being used as treatment for leukemia. Several IBMTR studies have identified variables predicting outcome in allogeneic transplants. These studies have also identified factors like GVL that increase our understanding of leukemia treatment.
P A, Rowlings +3 more
openaire +2 more sources
Allogeneic bone marrow transplantation
Seminars in Oncology Nursing, 1994From highly investigational to standardized therapy, allogeneic BMT has established its role in the treatment of selected diseases. Continued refinements in bone marrow transplantation will increase the number of potential candidates, reduce associated risks, and improve disease-free survival rates.
T, Franco, D A, Gould
openaire +2 more sources